The miniature robots should be launched on the marketplace by the end of 2018, take up very little room compared to previous systems and can be very easily used by the respective surgeon. The acquisition costs for broad-based use in the clinical routine should be considerably lower than the price of large, conventional surgical robots.
On balance, the development time for the system lasted close to fifteen years. The basic system is conceived as a platform and has already been certified in Europe and the USA. iSYS has concluded a joint venture with Medtronic, the largest American medical engineering company, and is also part of the Austrian Center for Medical Innovation and Technology (ACMIT) based in Wiener Neustadt. All in all, ACMIT will carry out research projects valued at EUR 18.7 million in the period 2017—2021.